Departed
George McNellage
Director
VSEE ·
VSEE HEALTH, INC.
Scott Wolf, Frank Ciufo, and George McNellage ceased serving on the Board
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8451–8500 of 33117
Departed
Matthias Alder
Chief Executive Officer
GANX ·
Gain Therapeutics, Inc.
On June 25, 2024, Matthias Alder (“Mr. Alder”), Chief Executive Officer of Gain Therapeutics, Inc. (the “Company”), and the Company mutually agreed that his service as Chief Executive Officer of the Company would terminate so that Mr. Alder can pursue other opportunities.
Departed
Min Wei
Chief Operating Officer
RVYL ·
RYVYL Inc.
Effective June 26, 2024, Min Wei resigned as Chief Operating Officer of RYVYL Inc.,
Departed
Jason Tardio
Chief Operating Officer
OVID ·
Ovid Therapeutics Inc.
Jason Tardio will cease serving as the Company’s Chief Operating Officer.
Departed
Thomas Perone
General Counsel, Chief Compliance Officer and Corporate Secretary
OVID ·
Ovid Therapeutics Inc.
on the Separation Date, Thomas Perone will cease serving as the Company’s General Counsel, Chief Compliance Officer and Corporate Secretary
Departed
Timothy Eriksen
director
TSR INC
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Robert Fitzgerald
director
TSR INC
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Bradley Tirpak
director
TSR INC
As of the Effective Time, Robert Fitzgerald, Timothy Eriksen and Bradley Tirpak each ceased to be directors of the Company and members of any committee of the Company’s board of directors.
Departed
Davinder Singh
Chief Financial Officer
TCX ·
TUCOWS INC /PA/
On June 24, 2024, Davinder Singh, the Chief Financial Officer of Tucows Inc. (the “Company”) informed the Board of Directors of the Company (“Board”) of his decision to voluntarily resign from his position to pursue other professional opportunities.
Departed
Steve Richie
General Counsel and Secretary
LSF ·
Laird Superfood, Inc.
The Company and Mr. Richie mutually agreed that Mr. Richie's resignation will be effective as of July 8, 2024.
Departed
Mark Bonyhadi
Director
TC BioPharm (Holdings) plc
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
Departed
Edward Niemzyck
Director
TC BioPharm (Holdings) plc
On June 26, 2024, each of Mark Bonyhadi and Edward Niemzyck submitted his respective resignation to the board of directors of TC Biopharm (Holdings) PLC (the “Company”), effective immediately.
Departed
James P. Geiskopf
Director
WAST ·
WASTE ENERGY CORP.
On June 26, 2024, James P. Geiskopf, a member of the Board of Directors of MetaWorks Platforms, Inc. and Chairman of the Audit Committee thereof, notified the Company of his intention to resign from the Company’s Board of Directors, effective June 28, 2024.
Departed
Jack Kenny
Chairman of the Board
BMRA ·
BIOMERICA INC
On June 26, 2024, Mr. Jack Kenny notified Biomerica, Inc. (the "Company") of his resignation as a member of the board of directors of the Company (the "Board") and all committees thereof, and as the Company’s Chairman of the Board, effective immediately.
Departed
Gurminder Bedi
Class I director
BLBD ·
Blue Bird Corp
On June 26, 2024, Gurminder Bedi, a Class I director of Blue Bird Corporation (the “Company”), informed our Chairman of the Board that he was resigning from our Board of Directors, effective immediately.
Departed
Joseph J. D'Ambrisi
Executive Vice President, Head of Electronics
ESI ·
Element Solutions Inc
Joseph J. D'Ambrisi will resign as Executive Vice President, Head of Electronics and a named executive officer of the Company, effective July 1, 2024.
Departed
Dr. Hong Wang
Director
HFFG ·
HF Foods Group Inc.
On June 25, 2024, Dr. Hong Wang informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of his intention to resign from the Board and all committees thereof, effective June 28, 2024.
Departed
Chi Wai (Michael) Woo
Chief Executive Officer, Chief Financial Officer, President, Treasurer, Director
EEGI ·
Eline Entertainment Group, Inc.
Effective June 28, 2024, the Company accepted the resignation of Chi Wai ( Michael) Woo as the CEO, CFO, President, Treasurer, and as a member of the Company’s Board of Directors.
Departed
Brian L, Ferdinand
director
LUXURBAN HOTELS INC.
Effective June 26, 2024, Brian L, Ferdinand, our company’s founder, and our former chairman of the board and chief executive officer, resigned as a member of the board.
Departed
Douglas L. Peterson
Chief Executive Officer and President
SPGI ·
S&P Global Inc.
Douglas L. Peterson will be retiring as Chief Executive Officer and President of the Company, effective as of November 1, 2024
Departed
Marc Maun
Executive Vice President – Regional Banking
BOKF ·
BOK FINANCIAL CORP
Marc Maun, Executive Vice President – Regional Banking, has announced plans to step down from his current position effective March 31, 2025.
Departed
Steven J. Collins
Director
BRAND HOUSE COLLECTIVE, INC.
On June 26, 2024, the Board of Directors voted to accept the resignations of Mr. Collins and Mr. Orr, effective immediately.
Departed
R. Wilson Orr, III
Director
BRAND HOUSE COLLECTIVE, INC.
On June 26, 2024, the Board of Directors voted to accept the resignations of Mr. Collins and Mr. Orr, effective immediately.
Departed
Jin-Long Chen
Director
TNYA ·
Tenaya Therapeutics, Inc.
On June 25, 2024, Jin-Long Chen submitted his resignation as a director of Tenaya Therapeutics, Inc.
Departed
Torsten Hombeck
Chief Financial Officer
AWHL ·
Aspira Women's Health Inc.
On June 27, 2024, the Compensation Committee (the “Committee”) of Aspira Women’s Health Inc. (the “Company”) determined that a personal civil matter interfered with Dr. Torsten Hombeck’ s ability to continue to serve as the Company’s Chief Financial Officer.
Departed
Jason Throne
Chief Legal Officer and Secretary
IDYA ·
IDEAYA Biosciences, Inc.
On June 21, 2024, Jason Throne informed IDEAYA Biosciences, Inc. (the “Company”) of his voluntary resignation from his positions as Chief Legal Officer and Secretary of the Company.
Departed
Timothy A. Welsh
Vice Chair, Consumer and Business Banking
USB ·
US BANCORP DE
On June 27, 2024, U.S. Bancorp (the “Company”) announced certain organizational changes, including that Timothy A. Welsh will cease to serve as Vice Chair, Consumer and Business Banking, effective July 31, 2024.
Departed
Jason Blessing
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Alan Henricks
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Manisha Gulati
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Kimberly DeCarlis
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Dave Yarnold
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Baljit Dail
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Tim Adams
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Scott Reese
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
Melissa Fisher
Director
MODEL N, INC.
At the Effective Time, pursuant to the Merger Agreement, Tim Adams, Jason Blessing, Baljit Dail, Kimberly DeCarlis, Melissa Fisher, Manisha Gulati, Alan Henricks, Scott Reese and Dave Yarnold, each of whom was a director of Model N as of immediately prior to the Effective Time, ceased to be a director of Model N and a member of any committee of Model N’s Board of Directors, and the directors of Merger Sub immediately prior to the Effective Time became the directors of Model N.
Departed
David S. Smith
Vice President, Chief Financial Officer and Treasurer
ALOT ·
AstroNova, Inc.
David S. Smith announced his decision to retire from his positions as Vice President, Chief Financial Officer and Treasurer of AstroNova, Inc.
Departed
Jessie English
Director
SNSE ·
Sensei Biotherapeutics, Inc.
On June 26, 2024, Jessie English, PhD notified the Chair of the Board of Directors (the “Board”) of Sensei Biotherapeutics, Inc. (the “Company”) of her decision to resign from the Board, effective July 1, 2024.
Departed
Anna Zhou
Chief Executive Officer, Company Secretary and Director
Chenghe Acquisition II Co.
Effective June 21, 2024, Anna Zhou resigned from her positions as chief executive officer, company secretary and member of the board of directors (the “Board”) of Chenghe Acquisition II Co. (the “Company”).
Departed
Todd Dissinger
Chief Financial Officer
NGVC ·
Natural Grocers by Vitamin Cottage, Inc.
On June 27, 2024, Todd Dissinger, Chief Financial Officer (principal financial officer) of Natural Grocers by Vitamin Cottage, Inc. (the “Company”) and its wholly owned subsidiary Vitamin Cottage Natural Food Markets, Inc., notified the Company that he intends to retire from the Company effective on or about December 31, 2024.
Departed
Ken Plunk
Senior Vice President and Chief Financial Officer
JJSF ·
J&J SNACK FOODS CORP
On June 24, 2024, Ken Plunk, Senior Vice President and Chief Financial Officer of J & J Snack Foods Corp. (the “Company”), notified the Company of his decision to retire from the Company effective December 31, 2024.
Departed
Joseph Risico
Co-Chief Executive Officer
ATER ·
Aterian, Inc.
On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.
Departed
Ahmad Moradi
Chairman of the Board
CRWE ·
Crown Equity Holdings, Inc.
announced today the resignation of Ahmad Moradi as its Chairman of the Board.
Departed
David Sidransky
Director
Orgenesis Inc.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
Departed
Mario Philips
Director
Orgenesis Inc.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
Departed
Guy Yachin
Director
Orgenesis Inc.
each of Guy Yachin, Dr. David Sidransky and Mario Philips did not stand for re-election at the Annual Meeting. Accordingly, the terms of each of Mr. Yachin, Dr. Sidransky and Mr. Philips on the Board of Directors ended effective as of June 27, 2024.
Departed
Harry Schulman
Director
BMTM ·
Bright Mountain Media, Inc.
On June 21, 2024, Harry Schulman, a director of the Company, notified the Company that he was resigning from the Board, effective June 30, 2024
Departed
W. Kip Speyer
Chairman
BMTM ·
Bright Mountain Media, Inc.
On June 21, 2024, W. Kip Speyer informed Bright Mountain Media, Inc. (the “Company”) that he will retire from his position as Chairman and as a member of the Board of Directors (the “Board”) of the Company effective June 30, 2024
Departed
Timothy O'Brien
director
MDRR ·
Medalist Diversified, Inc.
On June 26, 2024, Timothy O’Brien and Charles S. Pearson, Jr. notified the Board that they will each resign as a director of the Company, effective June 26, 2024.
Departed
Charles S. Pearson, Jr.
director
MDRR ·
Medalist Diversified, Inc.
On June 26, 2024, Timothy O’Brien and Charles S. Pearson, Jr. notified the Board that they will each resign as a director of the Company, effective June 26, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.